When evaluating the causality of an adverse event, which of the following should be a consideration?
a. The method used to randomize subjects
b. Whether or not the adverse event qualifies as a serious adverse event
c. The number of planned interventions in the protocol
d. The timing of the event in relation to administration of the investigational agent